(Q47173322)

English

Neocortical serotonin2A receptor binding predicts quetiapine associated weight gain in antipsychotic-naive first-episode schizophrenia patients

scientific article published on 15 May 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

11 January 2018

http://europepmc.org/abstract/MED/24830305

Neocortical serotonin2A receptor binding predicts quetiapine associated weight gain in antipsychotic-naive first-episode schizophrenia patients (English)

1 reference

Europe PubMed Central

11 January 2018

http://europepmc.org/abstract/MED/24830305

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Gitte Moos Knudsen

5

1 reference

Europe PubMed Central

11 January 2018

http://europepmc.org/abstract/MED/24830305

Lars Hageman Pinborg

4

object named as

Lars H Pinborg

0 references

Birte Yding Glenthøj

6

object named as

Birte Glenthøj

0 references

author name string

Hans Rasmussen

1

1 reference

Europe PubMed Central

11 January 2018

http://europepmc.org/abstract/MED/24830305

Bjørn H Ebdrup

2

1 reference

Europe PubMed Central

11 January 2018

http://europepmc.org/abstract/MED/24830305

B Oranje

3

1 reference

Europe PubMed Central

11 January 2018

http://europepmc.org/abstract/MED/24830305

publication date

15 May 2014

1 reference

Europe PubMed Central

11 January 2018

http://europepmc.org/abstract/MED/24830305

number of pages

8

0 references

The International Journal of Neuropsychopharmacology

1 reference

Europe PubMed Central

11 January 2018

http://europepmc.org/abstract/MED/24830305

17

1 reference

Europe PubMed Central

11 January 2018

http://europepmc.org/abstract/MED/24830305

11

1 reference

Europe PubMed Central

11 January 2018

http://europepmc.org/abstract/MED/24830305

1729-1736

1 reference

Europe PubMed Central

11 January 2018

http://europepmc.org/abstract/MED/24830305

The debate over dopamine's role in reward: the case for incentive salience

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000777

21 January 2018

Hippocampal and caudate volume reductions in antipsychotic-naive first-episode schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000777

21 January 2018

Important messages in the 'post': recent discoveries in 5-HT neurone feedback control

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000777

21 January 2018

5-HT2A receptor gene promoter polymorphism in relation to abdominal obesity and cortisol

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000777

21 January 2018

Atypical antipsychotic-induced weight gain: insights into mechanisms of action

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000777

21 January 2018

Occupancy of striatal and extrastriatal dopamine D2 receptors by clozapine and quetiapine.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000777

21 January 2018

Antipsychotic use in children and adolescents: minimizing adverse effects to maximize outcomes

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000777

21 January 2018

5-HT2A receptor gene polymorphism and eating disorders

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000777

21 January 2018

Serotonin alterations in anorexia and bulimia nervosa: new insights from imaging studies

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000777

21 January 2018

Hyperphagia and Obesity Following Serotonin Depletion by Intraventricular p -Chlorophenylalanine

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000777

21 January 2018

Serotonin2A receptor blockade and clinical effect in first-episode schizophrenia patients treated with quetiapine.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000777

21 January 2018

Evidence that central 5-HT2A and 5-HT2B/C receptors regulate 5-HT cell firing in the dorsal raphe nucleus of the anaesthetised rat.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000777

21 January 2018

Decreased Frontal Serotonin2A Receptor Binding in Antipsychotic-Naive Patients With First-Episode Schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000777

21 January 2018

Endocrine abnormalities of obesity.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000777

21 January 2018

Serotonin receptors

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000777

21 January 2018

A database of [(18)F]-altanserin binding to 5-HT(2A) receptors in normal volunteers: normative data and relationship to physiological and demographic variables

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000777

21 January 2018

A Systematic Review of Mortality in Schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000777

21 January 2018

Severe mental illness and risk of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000777

21 January 2018

Arterial stiffness and stroke in hypertension: therapeutic implications for stroke prevention

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000777

21 January 2018

Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000777

21 January 2018

Serotonin 5-HT2 receptors in schizophrenia: a PET study using [18F]setoperone in neuroleptic-naive patients and normal subjects.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000777

21 January 2018

Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000777

21 January 2018

Consensus nomenclature for in vivo imaging of reversibly binding radioligands

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000777

21 January 2018

5-HT2A/2C receptor and 5-HT transporter densities in mice prone or resistant to chronic high-fat diet-induced obesity: a quantitative autoradiography study

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000777

21 January 2018

Simplified reference tissue model for PET receptor studies.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000777

21 January 2018

Binding characteristics of the 5-HT2A receptor antagonists altanserin and MDL 100907.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000777

21 January 2018

A positron emission tomography study of quetiapine in schizophrenia: a preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancy

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000777

21 January 2018

Olanzapine differentially affects 5-HT2Aand2C receptor mRNA expression in the rat brain.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000777

21 January 2018

Reproducibility of 5-HT2A receptor measurements and sample size estimations with [18F]altanserin PET using a bolus/infusion approach

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000777

21 January 2018

Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000777

21 January 2018

Mechanism of Action of Atypical Antipsychotic Drugs and the Neurobiology of Schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000777

21 January 2018

Synthesis and in vitro affinities of various MDL 100907 derivatives as potential 18F-radioligands for 5-HT2A receptor imaging with PET.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000777

21 January 2018

Differential metabolic effects of antipsychotic treatments

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000777

21 January 2018

Paradoxical trafficking and regulation of 5-HT(2A) receptors by agonists and antagonists

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000777

21 January 2018

D(2) and 5HT(2A) receptor occupancy of different doses of quetiapine in schizophrenia: a PET study

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000777

21 January 2018

Time course of central nervous dopamine-D2 and 5-HT2 receptor blockade and plasma drug concentrations after discontinuation of quetiapine (Seroquel) in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000777

21 January 2018

Preventing cancer, cardiovascular disease, and diabetes: a common agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000777

21 January 2018

Brain serotonin 2A receptor binding: relations to body mass index, tobacco and alcohol use.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000777

21 January 2018

Serotonin 2A receptor antagonists for treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000777

21 January 2018

Metabolic and cardiovascular adverse effects associated with antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000777

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantification of 5-HT2A receptors in the human brain using [18F]altanserin-PET and the bolus/infusion approach

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000777

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterization of radioactive metabolites of 5-HT2A receptor PET ligand [18F]altanserin in human and rodent

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000777

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1017/S1461145714000777

1 reference

Europe PubMed Central

11 January 2018

http://europepmc.org/abstract/MED/24830305

1 reference

Europe PubMed Central

11 January 2018

http://europepmc.org/abstract/MED/24830305

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47173322&oldid=2143519987"